v3.26.1
Operating Leases
6 Months Ended
Jun. 30, 2026
Operating Leases [Abstract]  
Operating Leases

8. Operating Leases

 

The Company leases various facilities under operating leases. Leased facilities include manufacturing facilities, radiopharmaceutical production facilities, and office spaces. The Company combines lease and non-lease components, therefore there is no allocation of lease payments to non-lease components. Short-term leases with an initial term of 12 months or less are recognized on a straight-line basis over the lease term.

 

The components of total lease costs for operating leases during the three and six months ended June 30, 2026 and 2025 were as follows:

 

    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2026     2025     2026     2025  
Operating lease cost   $ 137     $ 126     $ 281     $ 263  
Variable lease cost     228       201       264       224  

 

The supplemental cash flow information related to operating leases during the three and six months ended June 30, 2026 and 2025 were as follows:

 

    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2026     2025     2026     2025  
Cash payment for operating lease   $ 131     $ 118     $ 275     $ 259  
Operating lease liabilities arising from obtaining new operating lease ROU assets during the period     162       653       162       817  

 

The weighted-average remaining lease terms and discount rates for operating leases as of June 30, 2026 and 2025 were as follows:

 

    June 30,
2026
    June 30,
2025
 
Weighted-average remaining lease term (years)     3.3       3.5  
Weighted-average discount rate     6.9 %     6.5 %

 

Future minimum lease payments under non-cancellable leases as of June 30, 2026, were as follows:

 

    Amount  
Remainder of 2026   $ 285  
2027     500  
2028     357  
2029     235  
2030     142  
Thereafter      
Total undiscounted lease payments     1,519  
Less: Imputed interest     (153 )
Operating lease liabilities   $ 1,366